Group B Streptococcus (GBS) is a leading cause of perinatal infectious diseases, particularly neonatal sepsis and meningitis. GBS is a bacterium that normally resides in the genital and gastrointestinal tracts of healthy adults, but it can be transmitted to the newborn during childbirth. In pregnant women, GBS screening is routinely performed around the 35th to 37th week of gestation to identify carriers. Infants born to GBS-positive mothers are at an increased risk of developing early-onset GBS disease, manifesting within the first week of life. Clinical features of early-onset GBS disease include respiratory distress, fever, lethargy, and poor feeding. Late-onset GBS disease can occur between the second week and several months of life, presenting with symptoms such as meningitis, sepsis, and pneumonia. Prevention strategies involve intrapartum antibiotic prophylaxis for GBS-positive pregnant women, which has significantly reduced the incidence of early-onset disease.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation